Prostate cancer is the fourth most common malignant tumor and the second most common in men. Prostate cancer is the most common cause of death from malignant tumors. It is expected that one in seven men will be diagnosed with prostate cancer during their lifetime. Currently, most cases are diagnosed by age 65, but it can occur in younger men. Therefore, an evaluation by a urologist is essential starting at age 45, or starting at age 40 if there is a first-degree relative with prostate cancer.

Prostate cancer can be treated and cured if identified early, which is why an evaluation by a urologist is essential starting at age 45, or at age 40 if there is a family history. Currently, the evaluation includes taking a blood sample (Prostate Specific Antigen), a digital rectal exam, and, depending on the case, imaging studies that can aid in the diagnosis, such as an MRI, are performed. If the criteria for prostate cancer are met, a prostate biopsy is required to confirm the diagnosis. Prostate cancer treatment is specifically targeted to the patient's characteristics and clinical stage. Treatment ranges from active surveillance, radical prostatectomy, radiotherapy, hormone therapy, chemotherapy, among others. We have the most up-to-date technology, resources, and experience to treat this disease.

Early-stage prostate cancer can be treated curatively with favorable prognoses, but this is not the case for patients diagnosed in advanced stages, where the prognosis is very poor.

Prostate cancer most commonly has no specific symptoms; it is asymptomatic. Other times, it can manifest with difficulty urinating, blood in the urine, erectile dysfunction, back pain, and other symptoms. Because it doesn't present specific initial symptoms, all men are required to seek preventive care.